Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Population Pharmacokinetic Modeling to Optimize the Dosage of the Piperacillin / Tazobactam Combination in Patients With Sepsis in Intensive Care

NCT03748095 is registered in ClinicalTrials.gov with University Hospital, Rouen as lead sponsor.

NCT NCT03748095
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03748095 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Population Pharmacokinetic Modeling to Optimize the Dosage of the Piperacillin / Tazobactam Combination in Patients With Sepsis in Intensive Care
Lead sponsor
University Hospital, Rouen
Phase
Observational
Overall status
Completed
Start date
March 12, 2019
Completion date
September 12, 2023
Enrollment
91 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

resuscitation patients with sepsis